The RLN2 gene helps make relaxin, a hormone that supports pregnancy by loosening certain tissues, helping blood vessels relax, and guiding changes in the uterus and cervix. This gene plays an important role in how your body adapts to pregnancy and manages some connective tissue changes. If it does not work as expected, these body changes may be less well coordinated, which can affect tissue flexibility and pregnancy related processes.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes give the directions for producing proteins, which are the working parts of cells. Other genes mainly control when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
RLN2Gene function
What if the gene works
The RLN2 gene helps make relaxin, a hormone active mainly during pregnancy. It helps blood vessels relax and connective tissues become more flexible, supporting changes in the uterus, cervix, and pelvic tissues.
Risk
What if the gene does not work
Changes in the RLN2 gene can reduce or alter the relaxin 2 signal that normally switches on the RXFP1 receptor. Milder variants may partly weaken this signaling, while more severe variants can greatly disrupt how the signal is made or released.
Treatment
What does that mean for your treatment
No RLN2-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the RLN2 gene. RLN2 and relaxin signaling are being studied as possible drug targets and biomarkers in cardiovascular, pregnancy, and fibrosis research, but this has not led to guideline-based treatment choices.
Gene function
What if the gene works
In the body, the RLN2 gene helps make relaxin-2, a hormone that supports tissue flexibility and blood flow. It is best known for helping the uterus, cervix, and nearby connective tissues adapt during pregnancy. This signaling also supports normal changes in blood vessels.
The RLN2 gene gives cells instructions to make relaxin-2. This hormone carries signals between tissues, especially in the reproductive system and blood vessels.
Relaxin-2 helps connective tissue loosen and remodel in a controlled way. This supports normal changes in the cervix, uterus, and pelvic tissues during pregnancy.
Relaxin-2 helps blood vessels relax and widen. This supports healthy circulation and some of the normal body adjustments that occur in pregnancy.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RLN2 gene can alter how the relaxin-2 signal is made, processed, and released from cells, which helps explain how RLN2 gene variants affect protein function. Milder variants may slightly change the hormone’s shape, stability, or receptor binding. More severe variants can disrupt the signal sequence, lower RNA or protein production, or create a shortened protein that is broken down before it can be secreted.
How variants are linked to conditions
Variants in the RLN2 gene do not yet have a broadly confirmed link to a specific health condition, although research on RLN2 gene variants linked to conditions is still evolving. Anyone with a confirmed variant in the RLN2 gene should rely on guidance from their doctor or genetic counselor to understand what it may mean for their own health and family history.
A variant is not necessarily a diagnosis
Human biology normally includes genetic variants, and they are common throughout the general population. Most of these variants do not have a direct impact on health and instead represent part of normal human diversity. With many genes, a variant connected with a condition indicates a potential association, not a definite diagnosis, especially when more than one gene and environmental factors contribute. Still, in some situations, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RLN2 gene. If RLN2 is discussed in your test results, its meaning usually depends on the wider clinical picture and family history rather than on clear, proven risk modifiers.
Inheritance of RLN2 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of the RLN2 gene variants tied to a specific human condition. In practice, inheritance of the RLN2 gene variants is not currently described in the same well-established way as classic autosomal dominant, autosomal recessive, or X-linked genetic conditions. The RLN2 gene is located on chromosome 9, which is an autosome. That means you inherit one copy of the RLN2 gene from your mother and one copy from your father.
What does my RLN2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, recognized condition for the RLN2 gene. If you have a specific RLN2 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for RLN2 variants usually uses a blood or saliva sample to read the RLN2 gene and look for DNA changes. It may be done as part of a larger panel or broader sequencing test, and the lab classifies any findings based on evidence about whether a variant is benign, uncertain, or linked to a health condition.
When should I consider getting a genetic test?
There isn’t yet a broadly established, RLN2-specific clinical reason for genetic testing. Decisions about testing are usually based on your personal health and family history, ideally with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but what it can tell you varies with the condition and the kind of variant present. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it acts, or how sensitive your body is to it. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one of several factors, along with age, other health conditions, and other medicines, that shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way medications work. By looking at patterns between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed and personalized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the RLN2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work. General questions about your health, side effects, or changes after starting or changing a medicine are best discussed with your doctor.
History
Relaxin was first identified in 1926, when researchers studying pregnancy in animals described a hormone that loosened pelvic tissues and softened the cervix. Initially understood only through visible traits, later recognized as tied to a specific gene, this work set the stage for identifying the human RLN2 gene decades later. As medical science evolved, so did understanding of this gene. By the late 20th century, scientists had cloned and mapped RLN2, separating it from related relaxin genes and clarifying its place in human reproductive biology. These historical steps shaped today’s understanding of how RLN2 entered genetics as part of a much older story about hormone research.